Worldwide Hematology Testing Industry to 2027 – by Product, Test Type, End-user and Geography

Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) — The “Hematology Testing Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Hematology Testing Market Report

The hematology testing market size was valued at USD 3,384.34 million in 2021 and is expected to reach USD 4,409.22 million by 2027, growing at a CAGR of 4.51% during the forecast period

Market Overview

The growth of the market can be attributed to the high prevalence/incidence of several acute, chronic, and infectious diseases, especially blood-related ailments. An increased number of programmed parameters in the hematology analyzers have increased their scope of usage in various new health condition diagnostics. The conventional methods are very expensive for the rare blood-related disorders in the market. There is a huge scope for hematology testing in the new disease conditions.

The following factors are likely to contribute to the growth of the hematology testing market –

• Artificial Intelligence in Hematology Testing
• Increase in Demand for Point of Care Hematology Testing
• Technological Advancements in Hematology Testing
• Increased Adoption of Telehealth
• Increasing Product Launches
• Integration of Flow-Cytometry with Hematology Analysers
• Increasing Blood Transfusions & Donations

Key Highlights

• At least once in a lifetime, 70% of the population will undergo the CBC test. The scope of CDC is increasing for various new diagnostics. This will drive the market largely.
• Due to the shortage of physicians and other benefits through the telehealth platforms, the hospitals are largely adopting telehealth. This scenario has a major impact on the hematology market. The doctors prescribe the tests, the patients are preferring to undergo tests in the nearby smaller diagnostic labs or physician offices and share the results in the telehealth platform.

Key Questions Answered:
1. What is the size of the hematology testing market?
2. What are the latest trends in the global hematology diagnostic market?
3. Which region has the highest share in the hematology testing market?
4. Who are the end-users in the hematology testing market?
5. Who are the key players in the hematology testing market?

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segment By Product
4.3.2 Market Segment By Test Type
4.3.3 Market Segment By End-User
4.3.4 Market Segmentation By Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market At A Glance

7 Introduction
7.1 Overview
7.2 Impact Of Covid-19 On Hematology Testing
7.2.1 Covid-19 An Opportunity For Hematology Testing

8 Market Opportunities & Trends
8.1 Artificial Intelligence In Hematology Testing
8.2 Increase In Demand For Point-Of-Care Hematology Testing
8.3 Technological Advancements In Hematology Testing
8.4 Increased Adoption Of Telehealth

9 Market Growth Enablers
9.1 Increasing Product Launches
9.2 Integration Of Flow Cytometry With Hematology Analyzers
9.3 Increasing Blood Transfusions & Donations

10 Market Restraints
10.1 Stringent Regulations Coupled With Product Recalls & Safety Concerns
10.2 High Initial Investment & Maintenance Of Hematology Analyzers
10.3 Lower-Than-Expected Penetration Of Advanced Hematology Analyzers In LMICS

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Consumables – Geography Segmentation
12.4 Analyzers
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Analyzers – Geography Segmentation

13 Analyzers – Part Differential
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 5&6-Part
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 5&6-Part Hematology Analyzers – Geography Segmentation
13.4 3-PART
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 3-Part Hematology Analyzers – Geography Segmentation

14 Analyzers – Volume
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Small & Medium Volume
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Small & Medium Volume – Geography Segmentation
14.4 High Volume
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 High Volume – Geography Segmentation

15 Test
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Routine Tests
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Routine Tests – Geography Segmentation
15.4 Specialty Tests
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Specialty Tests – Geography Segmentation

16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Hospitals
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Hospitals – Geography Segmentation
16.4 Standard Reference Laboratories
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Standard Reference Laboratories – Geography Segmentation
16.5 Blood Bank
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Blood Banks – Geography Segmentation
16.6 Others
16.6.1 Market Overview
16.6.2 Market Size & Forecast
16.6.3 Others – Geography Segmentation

17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview

18 North America

19 Europe

20 APAC

21 Latin America

22 Middle East & Africa

23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Abbott
23.2.2 Boule Diagnostics
23.2.3 Danaher
23.2.4 Diatron
23.2.5 HORIBA
23.2.6 NIHON KOHDEN
23.2.7 SHENZEN MINDRAY BIO-MEDICAL ELECTRONICS
23.2.8 Siemens Healthineers
23.2.9 Sysmex

24 Key Company Profiles
24.1 ABBOTT
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 BOULE DIAGNOSTICS
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 DANAHER
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 DIATRON
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 HORIBA
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
24.6 NIHON KOHDEN
24.6.1 Business Overview
24.6.2 Product Offerings
24.6.3 Key Strategies
24.6.4 Key Strengths
24.6.5 Key Opportunities
24.7 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
24.7.1 Business Overview
24.7.2 Product Offerings
24.7.3 Key Strategies
24.7.4 Key Strengths
24.7.5 Key Opportunities
24.8 SIEMENS HEALTHINEERS
24.8.1 Business Overview
24.8.2 Product Offerings
24.8.3 Key Strategies
24.8.4 Key Strengths
24.8.5 Key Opportunities
24.9 SYSMEX
24.9.1 Business Overview
24.9.2 Product Offerings
24.9.3 Key Strategies
24.9.4 Key Strengths
24.9.5 Key Opportunities

25 Other Prominent Vendors
25.1 ALPHA SCIENTIFIC
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 AGAPPE DIAGNOSTICS
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 ANALYTICON BIOTECHNOLOGIES
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 BALIO DIAGNOSTICS
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 B&E BIO-TECHNOLOGY
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 BIOSYSTEMS
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 BIOWAY BIOLOGICAL TECHNOLOGY
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 BIO-RAD
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 CLINDIAG SYSTEMS
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 CONTECH MEDICAL SYSTEMS
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 CONVERGENT TECHNOLOGIES
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 CPC DIAGNOSTICS
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 CPM SCIENTIFICA
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 DIAGON
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 DIRUI
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 DRUCKER DIAGNOSTICS
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 ERBA DIAGNOSTICS
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 EDAN INSTRUMENTS
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 F. HOFFMANN-LA ROCHE
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 GENRUI BIOTECH
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 HIGH TECHNOLOGY
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 SHENZHEN LANDWIND MEDICAL
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 LINEAR CHEMICALS
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 MACCURA BIOTECHNOLOGY
25.24.1 Business Overview
25.24.2 Product Offerings
25.25 MERIL LIFESCIENCES
25.25.1 Business Overview
25.25.2 Product Offerings
25.26 NORMA
25.26.1 Business Overview
25.26.2 Product Offerings
25.27 PRESTIGE DIAGNOSTICS
25.27.1 Business Overview
25.27.2 Product Offerings
25.28 SFRI
25.28.1 Business Overview
25.28.2 Product Offerings
25.29 SHENZHEN DYMIND BIOTECHNOLOGY
25.29.1 Business Overview
25.29.2 Product Offerings
25.30 SHENZHEN ICUBIO BIOMEDICAL TECHNOLOGY
25.30.1 Business Overview
25.30.2 Product Offerings
25.31 SHENZHEN PROKAN ELECTRONICS
25.31.1 Business Overview
25.31.2 Product Offerings
25.32 SPINREACT
25.32.1 Business Overview
25.32.2 Product Offerings
25.33 TRIVITRON HEALTHCARE
25.33.1 Business Overview
25.33.2 Product Offerings

26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations

27 Quantitative Summary

28 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/vde94i